SCHEMBL6746249

SCHEMBL6746249

CC(C)(C)c1ccc(S(OS(=O)(=O)c2cccc3cccc(OS(=O)(=O)c4ccccc4)c23)(c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.53
HSD17B3 P37058 1/20 0.53
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
ENPP1 P22413 4/20 0.39
ALDH1A1 P00352 5/20 0.37
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 2/20 0.36
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
ENPP3 O14638 3/20 0.34
HTR6 P50406 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743103 0.88 LMNA (0.46) HSD11B1HSD17B3METAP2METAP1ALDH1A1
SCHEMBL6745151 0.88 LMNA (0.46) HSD11B1HSD17B3METAP2METAP1ALDH1A1
SCHEMBL6745176 0.85 HSD11B1 (0.54) HSD11B1HSD17B3METAP2METAP1ENPP1
SCHEMBL6743646 0.84 MEN1 (0.48) HSD11B1HSD17B3METAP2METAP1ALDH1A1
SCHEMBL6740046 0.83 LMNA (0.40) HSD11B1HSD17B3METAP2METAP1ALDH1A1
SCHEMBL6740533 0.82 HSD11B1 (0.48) HSD11B1HSD17B3METAP2METAP1ENPP1
SCHEMBL6746238 0.81 HSD11B1 (0.50) HSD11B1HSD17B3METAP2METAP1ENPP1
SCHEMBL6740531 0.81 HSD11B1 (0.50) HSD11B1HSD17B3METAP2METAP1ENPP1
SCHEMBL451539 0.79 HSD11B1 (0.53) HSD11B1HSD17B3ENPP1ALDH1A1MAPT
SCHEMBL2634260 0.79 HSD11B1 (0.53) HSD11B1HSD17B3ENPP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6692893-B2 ONIUM SALTS OF ARYLSULFONYLOXYNAPHTHALENESULFONATE ANIONS WITH IODONIUM OR SULFONIUM CATIONS; USE IN DEEP ULTRAVIOLET LITHOGRAPHY SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-02-17 US disclosed
US-20020076643-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020076643-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process PNN, PI4K2B, PI4K2A HSD11B1 2902/4885HSD17B3 3207/4885METAP2 1511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.